Bortezomib in the Treatment of Multiple Myeloma

肿瘤学

原   价:
1105
售   价:
884.00
优惠
平台大促 低至8折优惠
作      者
出  版 社
出版时间
2010年11月15日
装      帧
精装
ISBN
9783764389475
复制
页      码
188
语      种
英语
综合评分
暂无评分
我 要 买
- +
库存 6 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways. This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个